Search

Displaying results 9361 - 9370 of 10000 in total
  1. Drug

    Onfekafusp alfa

    go.drugbank.com/drugs/DB16269
    Investigational

    Onfekafusp alfa is under investigation in clinical trial NCT02938299 (Neoadjuvant L19IL2/L19TNF- Pivotal Study).

  2. Drug

    AZD-7268

    go.drugbank.com/drugs/DB19203
    Investigational

    AZD-7268 is under investigation in clinical trial NCT01020799 (AZD7268 Safety and Tolerability Study).

    Synonyms: Benzamide, n-(2-hydroxyethyl)-n-methyl-4-(8-quinolinyl(1-(4-thiazolylmethyl)-4-piperidinylidene)methyl)-, N-(2-hydroxyethyl)-n-methyl-4-(8-quinolinyl(1-(4-thiazolylmethyl)-4-piperidinylidene)methyl)-benzamide
  3. Drug

    OXB-301

    go.drugbank.com/drugs/DB19269
    Investigational

    OXB-301 is under investigation in clinical trial NCT00397345 (Trovax Renal Immunotherapy Survival Trial).

  4. Drug

    Farampator

    go.drugbank.com/drugs/DB15012
    Investigational

    Farampator is under investigation in clinical trial NCT00113022 (Org 24448 to Treat Major Depression).

  5. Drug

    Fluciclovine

    go.drugbank.com/drugs/DB15237
    Investigational

    Fluciclovine is under investigation in clinical trial NCT03036943 (Fluciclovine (18F) Imaging of Breast Cancer).

  6. Drug

    ZR202-CoV

    go.drugbank.com/drugs/DB27995
    Investigational

    ZR202-CoV is a biologic drug. ZR202-CoV is under investigation in clinical trial NCT05490108 (Evaluation of Safety and Immunogenicity of the Recombinant ZR202-CoV and ZR202a-CoV Vaccines in Adults.).

  7. Drug

    ACCG-2671

    go.drugbank.com/drugs/DB33945
    Experimental

    ACCG-2671 is a small molecule drug. ACCG-2671 is under investigation in clinical trial NCT07815678 (First-in-human Study of the Safety, Tolerability, Pharmacokinetics, and Food Effect of ACCG-2671).

  8. Drug

    Coronavirus-Like Particle COVID-19 Vaccine

    go.drugbank.com/drugs/DB15852
    Experimental

    The Coronavirus-Like Particle COVID-19 Vaccine is in development and testing through Meidcago in Quebec City, Canada. … A Phase 1 clinical trial was launched in July 2020 evaluating the safety, tolerability, and immunogenicity of this vaccine candidate with or without either Cpg 1018 or AS03 (NCT04450004) in adults aged

  9. Drug

    Bamifylline

    go.drugbank.com/drugs/DB13203
    Investigational

    Bamifylline is a selective A1 adenosine receptor antagonist.

  10. Drug

    Avenciguat

    go.drugbank.com/drugs/DB18882
    Investigational

    Avenciguat is under investigation in clinical trial NCT05282121 (A Study to Test Whether BI 685509 Alone or in Combination With Empagliflozin Helps People With Liver Cirrhosis Caused by Viral Hepatitis … or Non-alcoholic Steatohepatitis (NASH) Who Have High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)).